πŸ‡ΊπŸ‡Έ FDA
Patent

US 7150984

Attenuated human rotavirus vaccine

granted A61KA61K2039/5254A61K2039/542

Quick answer

US patent 7150984 (Attenuated human rotavirus vaccine) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
49
CPC classes
A61K, A61K2039/5254, A61K2039/542, A61K39/12, A61K39/15